TATA Box Binding Protein Like 2 (Tbpl2) (N-Term) Peptide
-
- Target See all Tbpl2 products
- Tbpl2 (TATA Box Binding Protein Like 2 (Tbpl2))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- SGDFSSVDLS FLPDEVTQEN KDQPVISKHE TEENSESQSP QSRLPSPSEQ
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TBPL2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- Tbpl2 (TATA Box Binding Protein Like 2 (Tbpl2))
- Background
-
TBPL2 is a transcription factor required in complex with TAF3 for the differentiation of myoblasts into myocytes. The complex replaces TFIID at specific promoters at an early stage in the differentiation process.
Alias Symbols: TBP2, TRF3
Protein Size: 307 - Molecular Weight
- 33 kDa
- Gene ID
- 387332
- NCBI Accession
- NM_199047
- UniProt
- Q6SJ96
-